Last edition
News about "HRV Pharma high-potent APIs"
HRV Pharma Invests INR 150 Crore to Expand Peptide and High-Potent API Capabilities
HRV Pharma invests INR 150 crore to expand peptide and high-potent Active Pharmaceutical Ingredient (API) capabilities, strengthening its position in high-value pharmaceutical segments.
HRV Pharma High-potent APIs | 08/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members